Cargando…

Safety of adjuvant CDK4/6 inhibitors during the COVID-19 pandemic

Detalles Bibliográficos
Autores principales:	Pfeiler, Georg, DeMichele, Angela, Dueck, Amylou C, Fesl, Christian, Gnant, Michael, Mayer, Erica L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803349/ https://www.ncbi.nlm.nih.gov/pubmed/35114114 http://dx.doi.org/10.1016/S1470-2045(21)00708-7

Ejemplares similares

The dilemma of selecting a first line CDK4/6 inhibitor for hormone receptor-positive/HER2-negative metastatic breast cancer
por: Grinshpun, Albert, et al.
Publicado: (2023)

Potential through simplicity: thymidine kinase-1 as a biomarker for CDK4/6 inhibitors
por: McCartney, Amelia, et al.
Publicado: (2020)

Is Medication-Related Osteonecrosis of the Jaws (MRONJ) Associated to Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors? A Word of Cautiousness. Comment on Marcianò et al. Medication-Related Osteonecrosis of the Jaws and CDK4/6 Inhibitors: A Recent Association. Int. J. Environ. Res. Public Health 2020, 17, 9509
por: Fusco, Vittorio, et al.
Publicado: (2021)

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial
por: Gnant, M, et al.
Publicado: (2013)

More is not always better—what can be learned from the D-CARE trial
por: Pfeiler, Georg, et al.
Publicado: (2020)

Cdk5 and the mystery of synaptic vesicle endocytosis
por: Nguyen, Chan, et al.
Publicado: (2003)

Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors: existing and emerging differences
por: Johnston, Stephen, et al.
Publicado: (2023)

Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting
por: Skafida, Efthymia, et al.
Publicado: (2023)

Current safety preferences for intravitreal injection during COVID-19 pandemic
por: Shmueli, Or, et al.
Publicado: (2020)

Hyaluronan as an immunological adjuvant: a novel application for an ancient molecule
por: Carpanese, D., et al.
Publicado: (2023)

COVID-19 mRNA vaccine safety during the first 6 months of roll-out in the USA
por: Krantz, Matthew S, et al.
Publicado: (2022)

Inducible deletion of CDK4 and CDK6 – deciphering CDK4/6 inhibitor effects in the hematopoietic system
por: Maurer, Barbara, et al.
Publicado: (2020)

1-week hypofractionated adjuvant whole-breast radiotherapy: towards a new standard?
por: Levy, Antonin, et al.
Publicado: (2020)

Mixing mRNA, adenoviral, and spike-adjuvant vaccines for protection against COVID-19
por: Richardson, Christopher D
Publicado: (2022)

Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era
por: Gandini, Lucia, et al.
Publicado: (2023)

PERSEPHONE: are we ready to de-escalate adjuvant trastuzumab for HER2-positive breast cancer?
por: Pondé, Noam, et al.
Publicado: (2019)

Should adjuvant treatment be offered to patients with stage IB non-small cell lung cancer?
por: Passiglia, Francesco, et al.
Publicado: (2023)

How Africa Is Promoting Agricultural Innovations and Technologies amidst the COVID-19 Pandemic
por: Joseph Fernando, Angela
Publicado: (2020)

No patient safety without health worker safety
por: Shaw, Alexandra, et al.
Publicado: (2020)

Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors
por: Waissengrin, Barliz, et al.
Publicado: (2021)

Adjuvant chemotherapy for node negative, high Recurrence Score(TM) breast cancer: in defense of de-escalation
por: Lake, Diana, et al.
Publicado: (2019)

Ongoing asthma management in children during the COVID-19 pandemic: to step down or not to step down?
por: Abrams, Elissa Michele, et al.
Publicado: (2021)

A life-course model for healthier ageing: lessons learned during the COVID-19 pandemic
por: Jowell, Ashley, et al.
Publicado: (2020)

Population‐level evidence of survival benefits of patient‐reported outcome symptom monitoring software systems in routine cancer care
por: Basch, Ethan, et al.
Publicado: (2020)

Cancer pain treatment during the COVID-19 pandemic: institutional recommendations
por: Sousa, Angela Maria, et al.
Publicado: (2020)

Bisphosphonates in the adjuvant treatment of early breast cancer
por: Gnant, M
Publicado: (2009)

CDK 4/6 inhibitors for the treatment of meningioma
por: Young, Jacob S., et al.
Publicado: (2022)

CDK 4/6 inhibitors for adjuvant therapy in early breast cancer—Do we have a clear winner?
por: Akhade, Amol, et al.
Publicado: (2022)

Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer
por: Al-Qasem, Abeer J., et al.
Publicado: (2022)

Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. J. Pers. Med. 2023, 13, 553
por: Graziosi, Luigina, et al.
Publicado: (2023)

Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders
por: Wu, Xuewei, et al.
Publicado: (2021)

CDK6 Immunophenotype Implicates Potential Therapeutic Application of CDK4/6 Inhibitors in Urothelial Carcinoma
por: Sun, Ran, et al.
Publicado: (2022)

Indigenous health-care sovereignty defines resilience to the COVID-19 pandemic
por: Petrov, Andrey N, et al.
Publicado: (2023)

Challenges in lung cancer therapy during the COVID-19 pandemic
por: Calabrò, Luana, et al.
Publicado: (2020)

Medicinal plants for management of diabetes: alternative or adjuvant?
por: Shirpoor, Alireza
Publicado: (2017)

The EU's global action in support of universal health coverage in the time of the pandemic and beyond
por: Franz, Christian, et al.
Publicado: (2022)

AS03 stresses out macrophages: Commentary on ‘Activation of the endoplasmic reticulum stress sensor IRE1α by the vaccine adjuvant AS03 contributes to its immunostimulatory properties’
por: Orr, Mark T., et al.
Publicado: (2018)

Anatomy of a pandemic
por: Daszak, Peter
Publicado: (2012)

The ghost of pandemics past
por: Mack, Thomas M
Publicado: (2005)

The efficacy and safety of targeting GM-CSF in arthritis
por: Bykerk, Vivian P
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tn4qegt7f8q4ut084brn7v2mkj